 | • レポートコード：QYR2104Z0854 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、双極性障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（気分安定薬、抗精神病薬、抗うつ薬、その他薬品）、用途別市場規模（選択的セロトニン再取り込み阻害薬、セロトニン・ノルエピネフリン再取り込み阻害薬、三環系抗うつ薬、モノアミン酸化酵素阻害薬、ベンゾジアゼピン、ベータ遮断薬、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・双極性障害治療の市場動向 ・企業の競争状況、市場シェア ・双極性障害治療の種類別市場規模（気分安定薬、抗精神病薬、抗うつ薬、その他薬品） ・双極性障害治療の用途別市場規模（選択的セロトニン再取り込み阻害薬、セロトニン・ノルエピネフリン再取り込み阻害薬、三環系抗うつ薬、モノアミン酸化酵素阻害薬、ベンゾジアゼピン、ベータ遮断薬、その他） ・双極性障害治療の北米市場規模2016-2027（アメリカ、カナダ） ・双極性障害治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・双極性障害治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・双極性障害治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・双極性障害治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AstraZeneca、Bristol-Myers Squibb、Eli Lilly、Astellas Pharma、Allergan、Johnson & Johnson、GlaxoSmithKline、AbbVie、Pfizer、Novartis） ・結論 |
Bipolar disorder, also known as manic depression, is a mental disorder that could lead to periods of depression and elevated mood.
The treatment of bipolar disorder includes psychotherapy as well as medications such as mood stabilizers and antipsychotics.
Market Analysis and Insights: Global Bipolar Disorder Therapeutics Market
The global Bipolar Disorder Therapeutics market size is projected to reach US$ 4443.3 million by 2026, from US$ 3855.3 million in 2019, at a CAGR of 2.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bipolar Disorder Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bipolar Disorder Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bipolar Disorder Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bipolar Disorder Therapeutics market.
Global Bipolar Disorder Therapeutics Scope and Market Size
Bipolar Disorder Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bipolar Disorder Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Mood Stabilizers
Antipsychotic Drugs
Antidepressant Drugs
Other Drugs
Segment by Application
Selective Serotonin Reuptake Inhibitors
Serotonin-norepinephrine Reuptake Inhibitors
Tricyclic Antidepressants
Monoamine Oxidase Inhibitors
Benzodiazepines
Beta Blockers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Astellas Pharma
Allergan
Johnson & Johnson
GlaxoSmithKline
AbbVie
Pfizer
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bipolar Disorder Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Mood Stabilizers
1.2.3 Antipsychotic Drugs
1.2.4 Antidepressant Drugs
1.2.5 Other Drugs
1.3 Market by Application
1.3.1 Global Bipolar Disorder Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Selective Serotonin Reuptake Inhibitors
1.3.3 Serotonin-norepinephrine Reuptake Inhibitors
1.3.4 Tricyclic Antidepressants
1.3.5 Monoamine Oxidase Inhibitors
1.3.6 Benzodiazepines
1.3.7 Beta Blockers
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Bipolar Disorder Therapeutics Market Perspective (2016-2027)
2.2 Bipolar Disorder Therapeutics Growth Trends by Regions
2.2.1 Bipolar Disorder Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bipolar Disorder Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Bipolar Disorder Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Bipolar Disorder Therapeutics Industry Dynamic
2.3.1 Bipolar Disorder Therapeutics Market Trends
2.3.2 Bipolar Disorder Therapeutics Market Drivers
2.3.3 Bipolar Disorder Therapeutics Market Challenges
2.3.4 Bipolar Disorder Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bipolar Disorder Therapeutics Players by Revenue
3.1.1 Global Top Bipolar Disorder Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Bipolar Disorder Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Bipolar Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bipolar Disorder Therapeutics Revenue
3.4 Global Bipolar Disorder Therapeutics Market Concentration Ratio
3.4.1 Global Bipolar Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bipolar Disorder Therapeutics Revenue in 2020
3.5 Bipolar Disorder Therapeutics Key Players Head office and Area Served
3.6 Key Players Bipolar Disorder Therapeutics Product Solution and Service
3.7 Date of Enter into Bipolar Disorder Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bipolar Disorder Therapeutics Breakdown Data by Type
4.1 Global Bipolar Disorder Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Bipolar Disorder Therapeutics Forecasted Market Size by Type (2022-2027)
5 Bipolar Disorder Therapeutics Breakdown Data by Application
5.1 Global Bipolar Disorder Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Bipolar Disorder Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Bipolar Disorder Therapeutics Market Size (2016-2027)
6.2 North America Bipolar Disorder Therapeutics Market Size by Type
6.2.1 North America Bipolar Disorder Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Bipolar Disorder Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Bipolar Disorder Therapeutics Market Size by Type (2016-2027)
6.3 North America Bipolar Disorder Therapeutics Market Size by Application
6.3.1 North America Bipolar Disorder Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Bipolar Disorder Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Bipolar Disorder Therapeutics Market Size by Application (2016-2027)
6.4 North America Bipolar Disorder Therapeutics Market Size by Country
6.4.1 North America Bipolar Disorder Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Bipolar Disorder Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Bipolar Disorder Therapeutics Market Size (2016-2027)
7.2 Europe Bipolar Disorder Therapeutics Market Size by Type
7.2.1 Europe Bipolar Disorder Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Bipolar Disorder Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Bipolar Disorder Therapeutics Market Size by Type (2016-2027)
7.3 Europe Bipolar Disorder Therapeutics Market Size by Application
7.3.1 Europe Bipolar Disorder Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Bipolar Disorder Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Bipolar Disorder Therapeutics Market Size by Application (2016-2027)
7.4 Europe Bipolar Disorder Therapeutics Market Size by Country
7.4.1 Europe Bipolar Disorder Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Bipolar Disorder Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Bipolar Disorder Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Bipolar Disorder Therapeutics Market Size by Type
8.2.1 Asia-Pacific Bipolar Disorder Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bipolar Disorder Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bipolar Disorder Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Bipolar Disorder Therapeutics Market Size by Application
8.3.1 Asia-Pacific Bipolar Disorder Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bipolar Disorder Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bipolar Disorder Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Bipolar Disorder Therapeutics Market Size by Region
8.4.1 Asia-Pacific Bipolar Disorder Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bipolar Disorder Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Bipolar Disorder Therapeutics Market Size (2016-2027)
9.2 Latin America Bipolar Disorder Therapeutics Market Size by Type
9.2.1 Latin America Bipolar Disorder Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Bipolar Disorder Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Bipolar Disorder Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Bipolar Disorder Therapeutics Market Size by Application
9.3.1 Latin America Bipolar Disorder Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Bipolar Disorder Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Bipolar Disorder Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Bipolar Disorder Therapeutics Market Size by Country
9.4.1 Latin America Bipolar Disorder Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Bipolar Disorder Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bipolar Disorder Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Bipolar Disorder Therapeutics Market Size by Type
10.2.1 Middle East & Africa Bipolar Disorder Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bipolar Disorder Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bipolar Disorder Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Bipolar Disorder Therapeutics Market Size by Application
10.3.1 Middle East & Africa Bipolar Disorder Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bipolar Disorder Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bipolar Disorder Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Bipolar Disorder Therapeutics Market Size by Country
10.4.1 Middle East & Africa Bipolar Disorder Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bipolar Disorder Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Bipolar Disorder Therapeutics Introduction
11.1.4 AstraZeneca Revenue in Bipolar Disorder Therapeutics Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Bipolar Disorder Therapeutics Introduction
11.2.4 Bristol-Myers Squibb Revenue in Bipolar Disorder Therapeutics Business (2016-2021)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Bipolar Disorder Therapeutics Introduction
11.3.4 Eli Lilly Revenue in Bipolar Disorder Therapeutics Business (2016-2021)
11.3.5 Eli Lilly Recent Development
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Details
11.4.2 Astellas Pharma Business Overview
11.4.3 Astellas Pharma Bipolar Disorder Therapeutics Introduction
11.4.4 Astellas Pharma Revenue in Bipolar Disorder Therapeutics Business (2016-2021)
11.4.5 Astellas Pharma Recent Development
11.5 Allergan
11.5.1 Allergan Company Details
11.5.2 Allergan Business Overview
11.5.3 Allergan Bipolar Disorder Therapeutics Introduction
11.5.4 Allergan Revenue in Bipolar Disorder Therapeutics Business (2016-2021)
11.5.5 Allergan Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Bipolar Disorder Therapeutics Introduction
11.6.4 Johnson & Johnson Revenue in Bipolar Disorder Therapeutics Business (2016-2021)
11.6.5 Johnson & Johnson Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Bipolar Disorder Therapeutics Introduction
11.7.4 GlaxoSmithKline Revenue in Bipolar Disorder Therapeutics Business (2016-2021)
11.7.5 GlaxoSmithKline Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Bipolar Disorder Therapeutics Introduction
11.8.4 AbbVie Revenue in Bipolar Disorder Therapeutics Business (2016-2021)
11.8.5 AbbVie Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Bipolar Disorder Therapeutics Introduction
11.9.4 Pfizer Revenue in Bipolar Disorder Therapeutics Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Bipolar Disorder Therapeutics Introduction
11.10.4 Novartis Revenue in Bipolar Disorder Therapeutics Business (2016-2021)
11.10.5 Novartis Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Bipolar Disorder Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Mood Stabilizers
Table 3. Key Players of Antipsychotic Drugs
Table 4. Key Players of Antidepressant Drugs
Table 5. Key Players of Other Drugs
Table 6. Global Bipolar Disorder Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Bipolar Disorder Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Bipolar Disorder Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Bipolar Disorder Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Bipolar Disorder Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Bipolar Disorder Therapeutics Market Share by Regions (2022-2027)
Table 12. Bipolar Disorder Therapeutics Market Trends
Table 13. Bipolar Disorder Therapeutics Market Drivers
Table 14. Bipolar Disorder Therapeutics Market Challenges
Table 15. Bipolar Disorder Therapeutics Market Restraints
Table 16. Global Bipolar Disorder Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Bipolar Disorder Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Bipolar Disorder Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bipolar Disorder Therapeutics as of 2020)
Table 19. Ranking of Global Top Bipolar Disorder Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Bipolar Disorder Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Bipolar Disorder Therapeutics Product Solution and Service
Table 23. Date of Enter into Bipolar Disorder Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Bipolar Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Bipolar Disorder Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Bipolar Disorder Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Bipolar Disorder Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Bipolar Disorder Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Bipolar Disorder Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Bipolar Disorder Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Bipolar Disorder Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Bipolar Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Bipolar Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Bipolar Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Bipolar Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Bipolar Disorder Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Bipolar Disorder Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Bipolar Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Bipolar Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Bipolar Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Bipolar Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Bipolar Disorder Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Bipolar Disorder Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Bipolar Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Bipolar Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Bipolar Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Bipolar Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Bipolar Disorder Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Bipolar Disorder Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Bipolar Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Bipolar Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Bipolar Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Bipolar Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Bipolar Disorder Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Bipolar Disorder Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Bipolar Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Bipolar Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Bipolar Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Bipolar Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Bipolar Disorder Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Bipolar Disorder Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. AstraZeneca Company Details
Table 64. AstraZeneca Business Overview
Table 65. AstraZeneca Bipolar Disorder Therapeutics Product
Table 66. AstraZeneca Revenue in Bipolar Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 67. AstraZeneca Recent Development
Table 68. Bristol-Myers Squibb Company Details
Table 69. Bristol-Myers Squibb Business Overview
Table 70. Bristol-Myers Squibb Bipolar Disorder Therapeutics Product
Table 71. Bristol-Myers Squibb Revenue in Bipolar Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 72. Bristol-Myers Squibb Recent Development
Table 73. Eli Lilly Company Details
Table 74. Eli Lilly Business Overview
Table 75. Eli Lilly Bipolar Disorder Therapeutics Product
Table 76. Eli Lilly Revenue in Bipolar Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 77. Eli Lilly Recent Development
Table 78. Astellas Pharma Company Details
Table 79. Astellas Pharma Business Overview
Table 80. Astellas Pharma Bipolar Disorder Therapeutics Product
Table 81. Astellas Pharma Revenue in Bipolar Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 82. Astellas Pharma Recent Development
Table 83. Allergan Company Details
Table 84. Allergan Business Overview
Table 85. Allergan Bipolar Disorder Therapeutics Product
Table 86. Allergan Revenue in Bipolar Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Allergan Recent Development
Table 88. Johnson & Johnson Company Details
Table 89. Johnson & Johnson Business Overview
Table 90. Johnson & Johnson Bipolar Disorder Therapeutics Product
Table 91. Johnson & Johnson Revenue in Bipolar Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 92. Johnson & Johnson Recent Development
Table 93. GlaxoSmithKline Company Details
Table 94. GlaxoSmithKline Business Overview
Table 95. GlaxoSmithKline Bipolar Disorder Therapeutics Product
Table 96. GlaxoSmithKline Revenue in Bipolar Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 97. GlaxoSmithKline Recent Development
Table 98. AbbVie Company Details
Table 99. AbbVie Business Overview
Table 100. AbbVie Revenue in Bipolar Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 101. AbbVie Recent Development
Table 102. Pfizer Company Details
Table 103. Pfizer Business Overview
Table 104. Pfizer Bipolar Disorder Therapeutics Product
Table 105. Pfizer Revenue in Bipolar Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 106. Pfizer Recent Development
Table 107. Novartis Company Details
Table 108. Novartis Business Overview
Table 109. Novartis Bipolar Disorder Therapeutics Product
Table 110. Novartis Revenue in Bipolar Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 111. Novartis Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bipolar Disorder Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Mood Stabilizers Features
Figure 3. Antipsychotic Drugs Features
Figure 4. Antidepressant Drugs Features
Figure 5. Other Drugs Features
Figure 6. Global Bipolar Disorder Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Selective Serotonin Reuptake Inhibitors Case Studies
Figure 8. Serotonin-norepinephrine Reuptake Inhibitors Case Studies
Figure 9. Tricyclic Antidepressants Case Studies
Figure 10. Monoamine Oxidase Inhibitors Case Studies
Figure 11. Benzodiazepines Case Studies
Figure 12. Beta Blockers Case Studies
Figure 13. Others Case Studies
Figure 14. Bipolar Disorder Therapeutics Report Years Considered
Figure 15. Global Bipolar Disorder Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Bipolar Disorder Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Bipolar Disorder Therapeutics Market Share by Regions: 2020 VS 2027
Figure 18. Global Bipolar Disorder Therapeutics Market Share by Regions (2022-2027)
Figure 19. Global Bipolar Disorder Therapeutics Market Share by Players in 2020
Figure 20. Global Top Bipolar Disorder Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bipolar Disorder Therapeutics as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Bipolar Disorder Therapeutics Revenue in 2020
Figure 22. Global Bipolar Disorder Therapeutics Revenue Market Share by Type (2016-2021)
Figure 23. Global Bipolar Disorder Therapeutics Revenue Market Share by Type (2022-2027)
Figure 24. North America Bipolar Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Bipolar Disorder Therapeutics Market Share by Type (2016-2027)
Figure 26. North America Bipolar Disorder Therapeutics Market Share by Application (2016-2027)
Figure 27. North America Bipolar Disorder Therapeutics Market Share by Country (2016-2027)
Figure 28. United States Bipolar Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Bipolar Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Bipolar Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Bipolar Disorder Therapeutics Market Share by Type (2016-2027)
Figure 32. Europe Bipolar Disorder Therapeutics Market Share by Application (2016-2027)
Figure 33. Europe Bipolar Disorder Therapeutics Market Share by Country (2016-2027)
Figure 34. Germany Bipolar Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Bipolar Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Bipolar Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Bipolar Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Bipolar Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Bipolar Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Bipolar Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Bipolar Disorder Therapeutics Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Bipolar Disorder Therapeutics Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Bipolar Disorder Therapeutics Market Share by Region (2016-2027)
Figure 44. China Bipolar Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Bipolar Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Bipolar Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Bipolar Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Bipolar Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Bipolar Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Bipolar Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Bipolar Disorder Therapeutics Market Share by Type (2016-2027)
Figure 52. Latin America Bipolar Disorder Therapeutics Market Share by Application (2016-2027)
Figure 53. Latin America Bipolar Disorder Therapeutics Market Share by Country (2016-2027)
Figure 54. Mexico Bipolar Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Bipolar Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Bipolar Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Bipolar Disorder Therapeutics Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Bipolar Disorder Therapeutics Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Bipolar Disorder Therapeutics Market Share by Country (2016-2027)
Figure 60. Turkey Bipolar Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Bipolar Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Bipolar Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. AstraZeneca Revenue Growth Rate in Bipolar Disorder Therapeutics Business (2016-2021)
Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Bipolar Disorder Therapeutics Business (2016-2021)
Figure 65. Eli Lilly Revenue Growth Rate in Bipolar Disorder Therapeutics Business (2016-2021)
Figure 66. Astellas Pharma Revenue Growth Rate in Bipolar Disorder Therapeutics Business (2016-2021)
Figure 67. Allergan Revenue Growth Rate in Bipolar Disorder Therapeutics Business (2016-2021)
Figure 68. Johnson & Johnson Revenue Growth Rate in Bipolar Disorder Therapeutics Business (2016-2021)
Figure 69. GlaxoSmithKline Revenue Growth Rate in Bipolar Disorder Therapeutics Business (2016-2021)
Figure 70. AbbVie Revenue Growth Rate in Bipolar Disorder Therapeutics Business (2016-2021)
Figure 71. Pfizer Revenue Growth Rate in Bipolar Disorder Therapeutics Business (2016-2021)
Figure 72. Novartis Revenue Growth Rate in Bipolar Disorder Therapeutics Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界の双極性障害市場規模・現状・予測（2021年-2027年） Bipolar disorder (formerly called manic-depressive illness or manic depression) is a mental disorder that causes unusual shifts in mood, energy, activity levels, concentration, and the ability to carry out day-to-day tasks. Market Analysis and Insights: Global Bipolar Disorder Market The global Bipo…- 世界のうつ病性障害市場規模・現状・予測（2021年-2027年） Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. It is a very common condition that affects 1 in every 5 Americans. There are many factors including…
- 世界の慢性うつ病パーソナリティ障害治療市場規模・現状・予測（2021年-2027年） Chronic depressive personality disorder also known as Dysthymia is a chronic form of depression. It is mild form of depression which last up to two years or more. This disorder is less severe in comparison to other forms of depression. Symptoms of chronic depressive personality disorder are loss of …
- 世界の産後うつ病治療薬市場規模・現状・予測（2021年-2027年） Postpartum depression is a prevalent disorder affecting many women of reproductive age. Mood stabilizing medications reduce the risk of postpartum bipolar depression relapse but no randomized controlled trials have examined their use in the acute or prophylactic treatment of postpartum bipolar depre…
- 世界のセロトニン症候群市場規模・現状・予測（2021年-2027年） Serotonin syndrome is a group of symptoms such as high body temperature, agitation, increased reflexes, tremor, sweating, dilated pupils, diarrhoea etc. due to use of serotonergic drugs. Serious complications such as seizures and extensive muscle breakdown may occur which may lead to death. US accou…